Patents by Inventor Marc Fisher

Marc Fisher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF G-CSF FOR THE EXTENSION OF THE THERAPEUTIC TIME-WINDOW OF THROMBOLYTIC STROKE THERAPY
    Publication number: 20120070403
    Abstract: The present invention relates to the use of G-CSF and derivatives thereof for extending the therapeutic window of subsequent thrombolytic treatment of acute stroke, and thereby, allowing the diagnostic examinations which are necessary prior to the thrombolytic treatment in order to avoid hemorrhagic and other severe adverse side effects of the thrombolysis.
    Type: Application
    Filed: February 17, 2010
    Publication date: March 22, 2012
    Applicant: SYGNIS BIOSCIENCE GMBH & CO. KG
    Inventors: Marc Fisher, Armin Schneider
  • Laser Decontamination of the Surface of a Profiled Part
    Publication number: 20080121248
    Abstract: The invention concerns laser decontamination of the surface of a shaped component (3). Said decontamination comprises the following steps: successively impinging parts of the surface of the shaped component (3) with pulsed laser beams of wavelengths in the ultraviolet range and enabling the surface layer of the shaped component (3) to be ablated in the form of particles, the laser beams being distributed so as to cover simultaneously each treated part; and recuperating by suction said particles.
    Type: Application
    Filed: December 12, 2005
    Publication date: May 29, 2008
    Applicant: Compagnie Generale Des Matieres Nuleaires
    Inventors: Bernard Turco, Marc Fisher
  • Reduction of infarct volume using citicoline
    Patent number: 5872108
    Abstract: The invention is directed to a method of reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia, by the administration of citicoline shortly after an ischemic episode and continuing daily treatment for up to about 30 days, preferably for at least about 6 weeks. The method is useful in the treatment of stroke and severe head trauma patients and maximizes the chances for a full or substantially full recovery of the patient.
    Type: Grant
    Filed: February 20, 1996
    Date of Patent: February 16, 1999
    Assignee: Interneuron Pharmaceuticals, Inc.
    Inventors: Bobby W. Sandage, Jr., Marc Fisher, Kenneth W. Locke
  • Method of protecting brain tissue from cerebral infarction subsequent to ischemia
    Patent number: 5827832
    Abstract: The invention is directed to a method of reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia, by the administration of citicoline shortly after an ischemic episode and continuing daily treatment for up to about 30 days, preferably for at least about 6 weeks. The method is useful in the treatment of stroke and severe head trauma patients and maximizes the chances for a full or substantially full recovery of the patient. Combination treatment regimens are also disclosed along with compositions for use therewith.
    Type: Grant
    Filed: March 1, 1996
    Date of Patent: October 27, 1998
    Assignee: Interneuron Pharmaceuticals, Inc.
    Inventors: Bobby W. Sandage, Jr., Marc Fisher, Kenneth W. Locke
  • Method of protecting brain tissue from cerebral infarction subsequent to ischemia
    Patent number: 5801160
    Abstract: Methods and pharmaceutical compositions for reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia.
    Type: Grant
    Filed: March 18, 1997
    Date of Patent: September 1, 1998
    Assignee: Interneuron Pharmaceuticals, Inc.
    Inventors: Bobby Winston Sandage, Marc Fisher, Kenneth Walter Locke